Related Article from Urokinase-Type Plasminogen Activator Receptor: A Beacon of Malignancy?

dataset

posted on 2023-03-31, 15:24 authored by Ronny Drapkin, Adam Clauss, Steven Skates

History

ARTICLE ABSTRACT

Discriminating between benign and malignant disease is a pivotal diagnostic issue in the care of women with pelvic masses. Identification of serum biomakers that can rellably make the distinction would aid in the proper referral for patient care and may provide leads in the development of early detection strategies.

Usage metrics

Keywords

Cancer Prevention Identification of new risk factors Gynecological Cancers Ovarian cancer

Licence

CC BY

Related Article from Urokinase-Type Plasminogen Activator Receptor: A Beacon of Malignancy?

History

ARTICLE ABSTRACT

Usage metrics

Categories

Keywords

Licence

Exports